PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

33,370 stories, page 21 of 557

Advanced search
🌍Researchdoi.org

Clinical Course and Treatment Outcomes of Vulvar Condylomas in Immunocompromised Women: A Retrospective Cohort Study

CrossrefOriginal source
🌍Researchdoi.org

Serum NOS1AP Concentration: Association with Clinical Polymorphism of Schizophrenia and Metabolic Syndrome

CrossrefOriginal source
🌍Researchdoi.org

A Blended Learning Approach to Online DBT Skills Training: Preliminary Clinical Outcomes

CrossrefOriginal source
🌍Researchdoi.org

Comparative genomics reveals genotype-phenotype concordance and cryptic resistomes in clinical Pseudomonas aeruginosa

CrossrefOriginal source
🌍Researchdoi.org

A Rapid Molecular Detection Method for Streptococcus agalactiae Based on Bacteriophage Lysin Lysis and Real-Time PCR

CrossrefOriginal source
🌍Researchdoi.org

Histological validation of barium-filled vascular channels detected by high-resolution peripheral quantitative computed tomography in rheumatoid arthritis: an exploratory cadaveric study

CrossrefOriginal source
🌍Researchdoi.org

Behavioural and psychological symptom determinants of carer burden across clinical syndromes associated with frontotemporal lobar degeneration and Alzheimer’s disease: a transdiagnostic analysis

CrossrefOriginal source
🌍Researchdoi.org

In vitro approaches for modelling gut-liver crosstalk in drug-induced liver injury

CrossrefOriginal source
🌍Researchdoi.org

Connective tissue graft wall technique for mandibular Class II furcation defects: Two case reports

CrossrefOriginal source
🌍Researchdoi.org

Development of a Biorelevant In Vitro Release System and Level A In Vitro‐In Vivo Correlation for Doxorubicin Hydrochloride Liposome Injection via Flow‐Through Cell Method

CrossrefOriginal source
🌍discoverynews.google.com

What the FDA’s New Psychedelic Framework Actually Means for the Clinic

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.com

Scholar Rock wins FDA approval for first drug to target SMA muscle loss

STATOriginal source
🌍discoverynews.google.com

Eli Lilly completes acquisition of AtaiBeckley, initiates delisting from Nasdaq By Investing.com

Investing.com AustraliaOriginal source
🌍discoverynews.google.com

Drugging the undruggable. The Melbourne biotech taking on the world

Forbes AustraliaOriginal source
🌍Researchuab.edu

UAB Hospital-Callahan Eye Urgent Care opens Oct. 1

University of Alabama at BirminghamOriginal source
🌍Industrynews.intermountainhealth.org

Montana Cancer Survivor Treated at Intermountain Health Encourages Screening, Shares Hope Ahead of Celebrate for Life Event

<![CDATA[Intermountain Health Newsroom]]>Original source
🌍Industrynews.intermountainhealth.org

The Power of Shared Pregnancy: Parents Build Bonds Before Babies' Arrival

<![CDATA[Intermountain Health Newsroom]]>Original source
🌍discoverynews.google.com

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Interim Dividend for 2026

marketscreener.comOriginal source
🌍discoverynews.google.com

China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Announces Board Changes

marketscreener.comOriginal source
🌍discoverynews.google.com

Teva Pharmaceutical Announces Major Senior Notes Financing

TipRanksOriginal source
🌍discoverynews.google.com

Could Tavapadon Change Parkinson's Care?

medscape.comOriginal source
🌍discoverynews.google.com

Axios Live: Research and manufacturing investments boost Philadelphia's biotech role

AxiosOriginal source
🇺🇸Researchnews.cuanschutz.edu

How CU Anschutz Is Bringing Precision Medicine to Patients With Rare Cancers

CU Anschutz MedicalOriginal source
🌍discoverynews.google.com

EXEL Stock Slides After FDA Adds Three Months To Cancer Drug Review — William Blair Sees More Swings In Near Term

TradingViewOriginal source
🌍discoverynews.google.com

Phase 3 SUMMIT Trial Tests AXS-05 for Smoking Cessation

Patient Care OnlineOriginal source
🌍discoverynews.google.com

Nanoscope advances gene-agnostic therapy for severe vision loss in RP

Drug Discovery NewsOriginal source
🌍discoverynews.google.com

Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates

KalkineOriginal source
🌍discoverynews.google.com

West Pharmaceutical stock gains after insider sale and strong Q2 figures

ad-hoc-news.deOriginal source
🌍discoverynews.google.com

FDA extends review of Exelixis drug application for metastatic colorectal cancer By Investing.com

Investing.com AustraliaOriginal source
🇺🇸Industrycertara.com

Pharmacometrics Approach Group in Japan 2026​

CertaraOriginal source
🌍Regulatoryargentina.gob.ar

ANMAT emitió una Carta de Advertencia a CSL Behring S.A. por incumplimientos a las Buenas Prácticas de Fabricación

ANMAT NoticiasOriginal source
🇧🇷Industryems.com.br

EMS leva 160 crianças e jovens de projetos sociais para conhecer o Museu do Futebol

EMS Pharma NewsOriginal source
🇧🇷Industryems.com.br

EMS VENCE PRÊMIO LUPA DE OURO 2024 NA CATEGORIA PRESCRIÇÃO – SISTEMA NERVOSO CENTRAL

EMS Pharma NewsOriginal source
🌍discoverynews.google.com

Assisted dying bill defeated in House of Commons

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.com

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.com

US FDA extends review of Exelixis’ cancer drug

PharmaLiveOriginal source
🌍discoverynews.google.com

Takeda bets on Brazil to expand dengue vaccine sales

Valor InternationalOriginal source
🌍discoverynews.google.com

First FDA-approved APDS treatment for kids 4–11 comes from Pharming Group N.V. (PHAR)

Stock TitanOriginal source
🌍discoverynews.google.com

Thailand seeks pharma deals to expand medical research and production

pattayamail.comOriginal source
🌍discoverynews.google.com

Gout Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight

openpr.comOriginal source
🌍Researchcordis.europa.eu

CORDIS project: More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

CORDISOriginal source
🌍Researchcordis.europa.eu

CORDIS project: Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology

CORDISOriginal source
🌍Researchcordis.europa.eu

CORDIS project: Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses

CORDISOriginal source
🌍Researchcordis.europa.eu

CORDIS project: Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage

CORDISOriginal source
🌍Researchcordis.europa.eu

CORDIS project: A PeRsOnalized Prevention roadmap for the future HEalThcare

CORDISOriginal source
🌍Researchcordis.europa.eu

CORDIS project: Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.

CORDISOriginal source
🌍Researchuc.cl

Gepe homenajea a Violeta Parra en el primer capítulo de “Sesiones Violeta”

PUC ChileOriginal source
🌍Industrynews.intermountainhealth.org

Intermountain Health Primary Children's Hospital Behavioral Health Campus in Taylorsville Marks One Year Anniversary

<![CDATA[Intermountain Health Newsroom]]>Original source
🌍discoverynews.google.com

OPC Pharmaceutical Joint Stock Company Announces Change In Certificate Of Business Registration

marketscreener.comOriginal source
🇺🇸CROppd.com

Advancing ADPKD clinical trials and emerging treatments

Thermo Fisher PPDOriginal source
🌍discoverynews.google.com

Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer

marketscreener.comOriginal source
🌍discoverynews.google.com

Healey meets with biotech startups to hear about financing needs

The Boston GlobeOriginal source
🌍discoverynews.google.com

Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In

BenzingaOriginal source
🌍discoverynews.google.com

Exelixis Stock Slips as FDA Delays Cancer Drug Review - Exelixis (NASDAQ:EXEL)

BenzingaOriginal source
🌍discoverynews.google.com

Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent Finding

Medical DailyOriginal source
🇺🇸Researchunc.edu

An open letter from University leadership: Hate has no place at Carolina

UNC Chapel HillOriginal source
🌍discoverynews.google.com

Ukrainian pharma exporters urge govt to establish procedures for renewing GMP certificates, road transport permits with Uzbekistan

Interfax-UkraineOriginal source
🌍discoverynews.google.com

Leen Kawas: How to Build More Resilient Medicine Supply Chains

impakter.comOriginal source
🌍discoverynews.google.com

Cybin (CN:HELP) Falls 5.91% as Clinical-Stage Risk and Phase 3 Expectations Pressure Sentiment

kalkine.caOriginal source
🌍Industrywuxibiologics.com

Monthly Biologics News & Articles | WuXi Biologics | September 2026

WuXi BiologicsOriginal source